Summary
Placental protein 19 (PP19) is one of the new placental tissue proteins identified in extracts from human term placenta by Bohn and Winkler [1]. We measured the PP19 concentration in body fluids and placental tissue by radioimmunoassay; the minimum detectable dose of standard was 1.5 ng/ml. Although ethylene diamine tetraacetic acid (EDTA-2K) inhibited the immunoreaction between PP19 (225/242) and anti-PP19 antibody (632 ZA), the PP19 concentration did not differ between serum and heparin and sodium citrate plasmas. The serum PP19 concentration was increased by hemolysis. In blood cell fractions separated by the Ficoll-Paque/Macrodex method, polymorphonuclear leukocyte fraction contained the highest PP19 concentration. The circulating serum PP19 concentration was 4.5±1.1 ng/ml (mean ± standard deviation) in the proliferative phase (n=8) and 5.1±1.6 ng/ml in the secretory phase (n=7) for nonpregnant women, and 4.6±2.2 ng/ml from men (n=12). Seminal plasma (n=8) contained 212.2±99.7 ng/ml. The maternal serum PP19 concentration in 291 normal pregnancies increased from 6.2 ng/ml (median) at 6–7 weeks of gestation to 34.1 ng/ml at 38–39 weeks. The mean PP19 concentration was higher in amniotic fluid and retroplacental blood, but lower in umbilical cord blood than that in circulating maternal serum. In hydatidiform mole, vesicular fluid contained high PP19 concentration (1154.6±659.5 ng/ml), although these maternal serum concentration was not statistically higher than normal range. The chorionic villous trophoblast contained more PP19 than decidua, chorion, and amnion. These results suggest that PP19 has an extraplacental source, even though the chorionic villous trophoblast may be the main source throughout pregnancy.
Similar content being viewed by others
References
Bohn H, Winkler W (1985) Isolation and characterization of four new placental tissue proteins (PP18, PP19, PP20, PP21). Arch Gynecol 236:235–242
Takayama M, Isaka K, Ogawa T, Funayama H, Yamabe S, Soma H, Bohn H (1988) Characteristic differences in immunohistochemical localization of new placental proteins (PP1, PP19, PP21) in the human placenta. Gynecol Obstet Invest 26:274–280
Takayama M, Isaka K, Suzuki Y, Funayama H, Suzuki Y, Akiya K, Bohn H (1989) Comparative study of placental protein 19, human chorionic gonadotrophin and pregnancy-specific β1-glycoprotein as immunohistochemical markers for extravillous trophoblast in pregnancy and trophoblastic disease. Histochemistry 93:167–173
Howell CL, Miller MJ, Martin WJ (1979) Comparison of rates of virus isolation from leukocyte populations separated from blood by conventional and Ficoll-Paque/Macrodex methods. J Clin Microbiol 10:533–537
Marchalonis JJ (1972) An enzymic method for the trace iodination of immunoglobulins and other proteins. Biochem J 113:299–305
Salem HT, Menabawey M, Seppälä M, Shaaban MM, Chard T (1984) Human seminal plasma contains a wide range of trophoblast-“specific” proteins. Placenta 5:413–417
Julknen M, Wahlstrom T, Seppälä M, Koistinen R, Koskimies AI, Stenman U-H, Bohn H (1985) Detection and localization of placental-protein-14-like protein in human seminal plasma and in the male. Arch Androl 12:59–67
Takayama M, Isaka K, Ogawa T, Funayama H, Yamabe S, Soma H, Bohn H (1988) Placental protein 21: localization in human placenta and concentrations in the body fluids of men and nonpregnant and pregnant women. Gynecol Obstet Invest 25:230–238
Tatra G, Breitenecker G, Gruber W (1974) Serum concentration of pregnancy specific beta-1 glycoprotein (SP-1) in normal and pathological pregnancies. Arch Gynaecol 217:383–390
Spellacy WN, Carlson KL, Birk S (1966) Dynamics of human placental lactogen. Am J Obstet Gynecol 96:1164–1173
Takayama M, Soma H, Saito T, Isaka K, Kashiwagi T, Ogawa T, Suzuki Y, Sayama S (1983) Circulating levels of placental protein 5 in normal and abnormal pregnancies. Gynecol Obstet Invest 16:13–26
Grudzinskas JG, Charnock M, Obiekwe BC, Gordon YB, Chard T (1979) Placental protein 5 in fetal and maternal compartments. Br J Obstet Gynecol 86:642–644
Rutanen EM, Bohn H, Seppälä M (1982) Radioimmunoassay of placental protein 12: levels in amniotic fluid, cord, and serum of healthy adults, pregnant women, and patients with trophoblastic disease. Am J Obstet Gynecol 144:460–464
Julkunen M, Rutanen EM, Koskimies A, Rata T, Bohn H, Seppälä M (1985) Distribution of placental protein 14 in tissues and body fluids during pregnancy. Br J Obstet Gynaecol 92:1145–1151
Grosignani PG, Nencioni T, Bramati B (1972) Concentration of chorionic gonadotrophin and chorionic somatomammotrophin in maternal serum, amniotic fluid, and cord blood serum at term. J Obstet Gynaecol Br Commonw 79:122–126
Würz H, Geiger W, Kunzing HJ, Jabs-Lehmann A, Bohn H, Lüben G (1981) Radioimmunoassay of SP1 (pregnancy-specific β1-glycoprotein) in maternal blood and in amniotic fluid in normal and pathologic pregnancies. J Pernat Med 2:67–75
Würz H, Lüben G, Bohn H, Kunzing H, Geite W (1983) Concentration of placental protein 10 (PP10) in maternal serum and amniotic fluid throughout normal gestation and in pregnancy complicated by fetal growth retardation. Arch Gynecol 233:165–174
Yuen HB (1987) Differing concentrations of human chorionic gonadotrophin and prolactin in the cyst fluid of hydatidiform mole and in amniotic fluid. Am J Obstet Gynecol 156:400–402
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Takayama, M., Isaka, K., Suzuki, Y. et al. Concentration of placental protein 19 in body fluid and placental tissues. Arch Gynecol Obstet 247, 83–93 (1990). https://doi.org/10.1007/BF02390665
Issue Date:
DOI: https://doi.org/10.1007/BF02390665